Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
World Sleep Disorders Market Analysis 2009-2024
Management Report
Published: June 2009
Pages: 153
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 1499.00 Buy Now!
Research from: Visiongain
Sector: Indication Areas
Sleep Disorders Still an Important Pharma Market: Our New Report – Sleep Disorders Market Analysis 2009-2024 - Explains Why, and How You Can Benefit
Sleep disorders affect hundreds of millions of people worldwide. It is a multi-billion dollar market for drug-based treatments with continuing potential for growth. This new report - World Sleep Disorders Market Analysis 2009-2024 - explains the commercial prospects for drugs to treat sleep disorders, an important, changing pharma market. The principal disorders are insomnia, narcolepsy, sleep apnea and restless leg syndrome, but there other potentially profitable market segments. Overall, sleep disorders are highly prevalent. Approximately 30% of the population worldwide suffer from sleep disorders analysis suggests. Capturing a segment of this market has enormous potential.
Total drug revenues in the sleep disorders market exceeded $7bn in 2008. Visiongain expects the market to expand during the forecast period 2009-2024 - but by how much? In this new study, you will discover market reach, both worldwide and in major national markets, with leading products and submarkets covered. Growth in the worldwide market will be driven by an increase in the use of insomnia-alleviating and wake-promoting drugs in particular. The treatment of insomnia and some other disorders will change during the forecast period - this report tells you how. An extensive pipeline with new treatment approaches - some close-to-market - will stimulate and increase profitablility in this market sector. A shift from traditional treatments to new drugs will improve treatment options, as well as broadening access to treatments, including use of generic substitutes. New drugs should provide more-attractive treatment options for patients and prescribers who have been deterred by the limitations of existing treatments.
Under-diagnosed and under-treated, sleep disorders present a significant market opportunity for existing and still-to-be-launched treatments. Currently, there is large untapped market potential in the sleep disorder market worldwide. Prescription drugs must compete with OTC products, natural remedies and other treatments, however. Under-treatment is widespread, with many sufferers not seeking medical guidance; that situation should gradually improve, increasing commercial opportunities. The full commercial potential of sleep disorder treatments has thus still to be achieved. The momentum in that sector will increase as companies further invest there, along with healthcare payers worldwide. This new report - Sleep Disorders Market Analysis 2009-2024 - is essential reading for anyone interested in the sleep disorders market. There, you will discover prospects for both existing competitors and potential market entrants from 2009 onwards.
Comprehensive analysis of the sleep disorders market area
Sleep Disorders Market Analysis 2009-2024 examines that market area critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are many tables and figures included. The result is a comprehensive market- and industry-centred report with detailed analyses and informed opinion to benefit your work.
Why you should buy Sleep Disorders Market Analysis 2009-2024
Benefits from purchasing this report include:
• Your receiving a comprehensive analysis of the prospects for sleep disorder treatments from 2009-2024, including predicted revenues, growth rates and other important data.
• Your accessing forecasts for the top-selling drugs in all the prominent sleep disorder markets, including detailed explanations of factors affecting individual drug sales.
• Your receiving sales forecasts for leading sleep disorder country markets worldwide
• Your identifying key pipeline developments, promising treatment avenues and emerging drug targets.
• Your receiving expert views from our original survey
• Your discovering the important drivers and restraints in the market, and how these operate worldwide
• Your finding out where the market is heading overall - both technologically and commercially - from the present onwards.
There is great untapped potential in the sleep disorder market. Safety and efficacy concerns still limit the commercial potential of sleep disorder drugs, despite the vast potential treatment population - one of the largest in medicine. Some market leaders will soon reach patent expiry. What effects will generic competition have in the market? Will more-effective treatments emerge soon, with commercial gains for innovators? What effects will OTC switching have? This report covers those important questions and many others.
You can order this report today
Anybody with an interest in the market for treating sleep disorders will gain valuable data and insight from this new study. This is an important market with significant potential for further sales growth and innovation. You can stay ahead by ordering this report today.
Sleep disorders affect hundreds of millions of people worldwide. It is a multi-billion dollar market for drug-based treatments with continuing potential for growth. This new report - World Sleep Disorders Market Analysis 2009-2024 - explains the commercial prospects for drugs to treat sleep disorders, an important, changing pharma market. The principal disorders are insomnia, narcolepsy, sleep apnea and restless leg syndrome, but there other potentially profitable market segments. Overall, sleep disorders are highly prevalent. Approximately 30% of the population worldwide suffer from sleep disorders analysis suggests. Capturing a segment of this market has enormous potential.
Total drug revenues in the sleep disorders market exceeded $7bn in 2008. Visiongain expects the market to expand during the forecast period 2009-2024 - but by how much? In this new study, you will discover market reach, both worldwide and in major national markets, with leading products and submarkets covered. Growth in the worldwide market will be driven by an increase in the use of insomnia-alleviating and wake-promoting drugs in particular. The treatment of insomnia and some other disorders will change during the forecast period - this report tells you how. An extensive pipeline with new treatment approaches - some close-to-market - will stimulate and increase profitablility in this market sector. A shift from traditional treatments to new drugs will improve treatment options, as well as broadening access to treatments, including use of generic substitutes. New drugs should provide more-attractive treatment options for patients and prescribers who have been deterred by the limitations of existing treatments.
Under-diagnosed and under-treated, sleep disorders present a significant market opportunity for existing and still-to-be-launched treatments. Currently, there is large untapped market potential in the sleep disorder market worldwide. Prescription drugs must compete with OTC products, natural remedies and other treatments, however. Under-treatment is widespread, with many sufferers not seeking medical guidance; that situation should gradually improve, increasing commercial opportunities. The full commercial potential of sleep disorder treatments has thus still to be achieved. The momentum in that sector will increase as companies further invest there, along with healthcare payers worldwide. This new report - Sleep Disorders Market Analysis 2009-2024 - is essential reading for anyone interested in the sleep disorders market. There, you will discover prospects for both existing competitors and potential market entrants from 2009 onwards.
Comprehensive analysis of the sleep disorders market area
Sleep Disorders Market Analysis 2009-2024 examines that market area critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are many tables and figures included. The result is a comprehensive market- and industry-centred report with detailed analyses and informed opinion to benefit your work.
Why you should buy Sleep Disorders Market Analysis 2009-2024
Benefits from purchasing this report include:
• Your receiving a comprehensive analysis of the prospects for sleep disorder treatments from 2009-2024, including predicted revenues, growth rates and other important data.
• Your accessing forecasts for the top-selling drugs in all the prominent sleep disorder markets, including detailed explanations of factors affecting individual drug sales.
• Your receiving sales forecasts for leading sleep disorder country markets worldwide
• Your identifying key pipeline developments, promising treatment avenues and emerging drug targets.
• Your receiving expert views from our original survey
• Your discovering the important drivers and restraints in the market, and how these operate worldwide
• Your finding out where the market is heading overall - both technologically and commercially - from the present onwards.
There is great untapped potential in the sleep disorder market. Safety and efficacy concerns still limit the commercial potential of sleep disorder drugs, despite the vast potential treatment population - one of the largest in medicine. Some market leaders will soon reach patent expiry. What effects will generic competition have in the market? Will more-effective treatments emerge soon, with commercial gains for innovators? What effects will OTC switching have? This report covers those important questions and many others.
You can order this report today
Anybody with an interest in the market for treating sleep disorders will gain valuable data and insight from this new study. This is an important market with significant potential for further sales growth and innovation. You can stay ahead by ordering this report today.
Companies Listed
Acadia
Actavis
Actelion
Alexza
Apotex
Arena
Astellas
Axxonis Pharma AG
Barr
Bayer
Bioprojet
Boehringer Ingelheim
BTG
Cephalon
Collegium
CoLucid
Cortex
Daiichi Sankyo
Eisai
Eli Lilly
Essential Nutrition
Evotec
Fabre Kramer
Forenap Pharma
Galleon
GlaxoSmithKline
Hypnion
Intra-Cellular Therapies
Italfarmaco
Jazz Pharmaceuticals
Kyowa Hakko Kirin
Meda
Merck & Co
Merck Serono
Mylan
Neurocrine Biosciences
Neurogen
Novadel
Orexo
Pfizer
Pharmascience
Ranbaxy
Sanofi-Aventis
Schering-Plough
Sepracor
SkyePharma
Somaxon
Somnus
Strada
Synosia Therapeutics
Takeda
Teva
Tikvah Therapeutics
Transcept
UCB Pharma
Valeant
Vanda
Watson
Wyeth
Xenoport